New blood test combo may spot sepsis death risk
NCT ID NCT06640504
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether combining standard infection markers (like lactate, CRP, and procalcitonin) with albumin levels could better predict death in sepsis patients in a surgical ICU. Researchers looked at 30 patients and calculated three ratios (lactate-to-albumin, CRP-to-albumin, and procalcitonin-to-albumin). The goal was to see if these ratios improve on traditional tests for spotting high-risk patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If the approach proves accurate, it could give doctors a simple, low-cost way to identify high-risk sepsis patients earlier.
- What could go wrong
- This was a very small study (30 people) and only looked back at existing data. Larger, real-time tests are needed to confirm if the method truly helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benha University
Banhā, El Qalyoubia, 13511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?